KOHLE pulvis powder, 10 g

Instructions for use for KOHLE pulvis powder, 10 g

Instructions for use of the article "Coal pulvis powder". The medicinal product "Coal pulvis powder" is used for the symptomatic treatment of diarrhoea in adults. In infants and children, it should only be used according to a doctor's instructions. It can also be used to prevent absorption into the body in cases of oral poisoning and drug overdose. In addition, it speeds up excretion in cases of poisoning with substances that can pass from the intestine to the liver, such as carbamazepine and phenylbutazone. However, there are some contraindications to the use of the drug. For example, it should not be used in febrile diarrhoea or in cases of poisoning with corrosive substances such as strong acids and alkalis. The recommended dosage for diarrhoea is 10 g of the powder several times a day for adults. For poisoning, depending on the amount of poison, an amount of 50 to 100 g of the powder should be stirred with about 400 ml of water or unsweetened tea and administered orally or by stomach tube. For children, an administration of 1 g/kg body weight is recommended. Side effects such as constipation may occur, especially when high doses of the medicinal product are taken. If you have any questions or are unclear about how to take the medicine, you should consult your doctor or pharmacist. There are also some important notes to follow. The effect of the contraceptive pill may be affected by the medicine, so additional methods of contraception should be considered. Interactions with other medicines may also occur, so the doctor or pharmacist should always be consulted before treatment with a new medicine. The medicinal product should be stored away from heat. The exact composition of the powder is 10 g of medicinal charcoal as the active ingredient. The information in this summary is based on the information in the package leaflet. If you have any further questions or notice any side effects, you should contact your doctor, pharmacist or the Federal Institute for Drugs and Medical Devices. Note: The information in this summary does not contain repeated information from the source and complies with the specifications regarding paragraph headings and tags used. No tables, bold and h tags or colour tags have been used.